Stress Relief Supplements Market Summary
As per Market Research Future Analysis, the Global Stress Relief Supplements Market was valued at USD 0.53 Billion in 2024 and is projected to reach USD 1.09 Billion by 2035, growing at a CAGR of 6.75% from 2025 to 2035. The market is driven by increasing consumer awareness of stress management benefits and a rise in stress-related health issues. The North American region is expected to dominate the market due to a focus on preventive healthcare and an aging population. Key segments include ashwagandha in sources, capsules & tablets in forms, and conventional in categories, with store-based distribution channels leading sales.
Key Market Trends & Highlights
The market is witnessing significant trends driven by health consciousness and product innovation.
- Market Size in 2024: USD 0.53 Billion
- Projected Market Size by 2035: USD 1.09 Billion
- CAGR from 2025 to 2035: 6.75%
- Dominant Source Segment: Ashwagandha
Market Size & Forecast
2024 Market Size | USD 0.53 Billion |
2035 Market Size | USD 1.09 Billion |
CAGR (2025-2035) | 6.75% |
Major Players
Key players include ADM (US), PharmalineaLid (Slovenia), Virtue Vitamins LIC (US), NaturesPlus (US), The Himalaya Drug Company (India), Plant Therapy Essential Oil (US), Cureveda (India), Naturalite Asia Co. Ltd. (Korea), Ricola (Switzerland), and Nutraceutical International Corporation.